000 01183 a2200373 4500
005 20250511173008.0
264 0 _c19760602
008 197606s 0 0 eng d
022 _a0009-9309
024 7 _a10.3109/15563657508990076
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aShulgin, A T
245 0 0 _aDrugs of abuse in the future.
_h[electronic resource]
260 _bClinical toxicology
_c1975
300 _a405-56 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAmphetamines
650 0 4 _aBarbiturates
650 0 4 _aBenzodiazepines
650 0 4 _aBenztropine
_xanalogs & derivatives
650 0 4 _aCocaine
_xanalogs & derivatives
650 0 4 _aDrug and Narcotic Control
650 0 4 _aForecasting
650 0 4 _aHallucinogens
650 0 4 _aHumans
650 0 4 _aMorphinans
650 0 4 _aMorphine Derivatives
650 0 4 _aNonprescription Drugs
650 0 4 _aPhencyclidine
650 0 4 _aSubstance-Related Disorders
_xclassification
650 0 4 _aUnited States
773 0 _tClinical toxicology
_gvol. 8
_gno. 4
_gp. 405-56
856 4 0 _uhttps://doi.org/10.3109/15563657508990076
_zAvailable from publisher's website
999 _c1227491
_d1227491